|Day's Range||9.72 - 9.72|
Inogen, Inc. (NASDAQ:INGN), which is in the medical equipment business, and is based in United States, received a lot...
Inogen (INGN) delivered earnings and revenue surprises of -10.00% and -5.55%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Inogen (NASDAQ: INGN ) announces its next round of earnings this Wednesday, August 7. Here is Benzinga's everything-that-matters guide for the Q2 earnings announcement. Earnings and Revenue Analysts covering ...
Inogen (INGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Inogen, Inc. , a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release second quarter 2019 financial results before market open on Wednesday, August 7, 2019.
Inogen Inc NASDAQ/NGS:INGNView full report here! Summary * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is moderate * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is moderate for INGN with between 5 and 10% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding INGN totaled $65.09 billion. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Reputable billionaire investors such as Jim Simons, Cliff Asness and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable assets would be required to invest in a hedge fund and most successful hedge funds won't accept your savings unless you commit at least $5 million) by pinpointing […]
Bragar Eagel & Squire is investigating certain officers and directors of Inogen, Inc., Health Insurance Innovations, Inc., Amyris, Inc., and Nutanix, Inc. More information about each potential case can be found at the link provided. Bragar Eagel and Squire is investigating certain officers and directors of Inogen following a class action complaint that was filed against Inogen on March 6, 2019.
Warning! GuruFocus has detected 3 Warning Signs with IRDM. The risk is very high with this kind of investment, but if investors look for companies that have no debt and a moderate to high current ratio, the risk can be significantly decreased. In addition, the companies have received an overweight recommendation rating from Wall Street, increasing the chances of a successful bet as these stocks are expected to outperform their industries within 12 months.
Inogen, Inc. , a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 39th Annual William Blair Growth Stock Conference in Chicago.